Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Research Reports > Fungal Testing Kits Market to Attain US$ 3.4 Bn Valuation through 2030, Says Future Market Insights in New Study

Research Reports

Fungal Testing Kits Market to Attain US$ 3.4 Bn Valuation through 2030, Says Future Market Insights in New Study

Published by linker 5

Posted on February 15, 2021

3 min read

Last updated: January 21, 2026

Bronchoscope with flexible design, essential for respiratory diagnostics - Global Banking & Finance Review — This image showcases a flexible bronchoscope, a crucial device for diagnosing respiratory conditions, aligning with the projected market growth to 2028. Its advanced functionality supports Covid-19 diagnostic applications.

The global fungal testing kits market is anticipated to grow strikingly at a CAGR of 10.2% amid the assessment period, 2020-2030.

Growing prevalence of systemic and superficial fungal infections, on-going schemes to promote and develop antifungal drugs testing, broader commercial accessibility of enhanced diagnostics, increasing awareness programs, heightening life expectancy and growth of real-time testing methods are projected to complement growth of the global market in the approaching years. Companies are focusing on making the kits affordable and cost-effective is at the keystone of vendors, since majority of the populace in growing economies have low disposable incomes. Thus, attempts are ongoing to offer affordable testing kits.

Governments are speeding up efforts to get over barriers such as conservative social and cultural perceptions in certain regions concerning certain diseases such as fungal infections.

With huge uncertainty looming over individual’s heads due to COVID-19 pandemic, a huge economic slump is on the cards. Despite this, the healthcare sector stay stoic, dedicated to eliminate the pandemic as soon as possible.

“Incessant focus on integrating technological progressions to enhance diagnostic outcomes stays the central objective of the companies, allowing them to expand their revenue pools,” opines FMI analyst.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-12418

Fungal Testing Kits Market – Major Takeaways

Medical diagnosis to stay fundamental application area, producing an attractiveness index of 2.8.
Skin samples are projected to gain the prominent share, holding more than 40% of the market due to a rising prevalance of superficial fungal infections such as yeast, athlete’s foot and ringworm infections.
Molecular detection tests to loom over others, accounting for US$ 1.6 Bn through 2030.
Broadening expenditure on healthcare infrastructure to elevate demand all over Asia-Pacific.

Fungal Testing Kits Market – Key Drivers

Growing geriatric population and vulnerability to the fungal infections has witnessed immense proliferation, which, in turn recorded an impressive upsurge in the market in the long term.
Increasing instances of several fungal infections and the commercial availability of diagnostic tests is burgeoning, this is projected to raise the market to higher echelons over the years to come.

Fungal Testing Kits Market – Regional Analysis

North America will remain as the dominant market, due to high occurrence and diagnostics of infectious ailments.
The European market for fungal testing kits is projected to account for significant sway, gaining close to 30% of the global revenue share during the assessment period.

Fungal Testing Kits Market – Competitive Landscape

Major companies identified in the global market for fungal testing kits include Thermo Fisher Scientific, Merck KGaA, bioMerieux SA, PerkinElmer Inc., ELITech Group, GenMark Diagnostics Incorporation, C.P.M. Diagnostic Research, Norgen Biotek, Biomed Diagnostics Incorporation, F.Hoffman LaRoche Limited., PCRmax, Bioquochem and Hologic Inc. Companies are focusing on partnerships, collaborations and acquisitions to develop lucrative diagnostic kits. For instance,

GenMark Diagnostics Inc. reported details concerning the effectivity of a PCR-based electrochemical detection and digital microfluidics system for fast recognition of 15 fungous pathogens. The system intends at finding pathogenic activity direct from positive blood cultures.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-12418

Fungal Testing Kits Market – Taxonomy

Test Type

Molecular Test
Chromogenic Test
Others

Sample Type

Skin
Urine
Vaginal Secretions
Blood
Cerebral
Others

Application

Research
Susceptibility Testing
Medical Diagnosis
Others

End-User

Diagnostic Laboratory
Hospitals
Pharmaceutical Companies
Research and Academic Institutes

Region:

North America
Latin America
Europe
South Asia
East Asia
Middle East & Africa
Oceania